Halozyme Therapeutics Inc... (HALO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

48.00

0.04%

After-hours Dec 13, 2024, 05:19 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01
Net Income	281.59M	202.13M	402.71M	129.09M	-72.24M	-80.33M	62.97M	-103.02M	-32.23M	-68.38M	-83.48M	-53.55M	-19.77M	-53.24M	-58.36M	-48.65M	-23.90M	-14.75M	-13.28M	-9.09M	-79.09K	-65.26K	-39.65K
Depreciation & Amortization	84.86M	49.64M	3.00M	3.28M	4.07M	2.39M	2.16M	2.41M	1.68M	1.76M	1.23M	1.08M	1.10M	1.51M	1.44M	1.05M	576.49K	244.00K	206.35K	123.35K	-	-	-
Stock-Based Compensation	36.62M	24.40M	20.82M	17.20M	34.78M	35.70M	30.67M	25.59M	20.84M	15.27M	9.54M	8.35M	5.57M	4.87M	4.53M	3.70M	-	-	-	-	-	-	-
Other Working Capital	4.10M	-9.06M	-11.55M	2.52M	-19.01M	278.49M	2.04M	5.63M	-17.02M	1.21M	-7.87B	3.26B	-732.71M	-4.85M	11.94M	9.97M	20.85M	20.46M	114.73K	1.20M	27.02K	7.14K	3.29K
Other Non-Cash Items	-10.33M	9.89M	24.61M	13.60M	-1.98M	1.70M	17.82M	7.11M	1.24M	2.02M	155.81K	8.63K	-1.57K	13.54K	2.69K	3.70M	2.58M	1.29M	185.20K	98.20K	2.34K	2.34K	1.99K
Deferred Income Tax	34.51M	40.01M	-155.43M	644.00K	490.00K	-3.08M	-257.00K	560.00K	887.00K	1.69M	1.12M	7.37K	-	-	-	-3.69M	-	-	-	-	-	-	-
Change in Working Capital	-38.67M	-85.95M	3.74M	-108.37M	-50.54M	-5.87M	20.69M	16.98M	-29.50M	106.00K	22.10M	-20.22M	-21.24M	1.47M	12.24M	8.53M	20.59M	20.30M	-112.41K	1.15M	27.02K	7.14K	3.29K
Operating Cash Flow	388.57M	240.11M	299.44M	55.45M	-85.42M	-49.50M	134.05M	-50.38M	-37.08M	-47.52M	-49.34M	-64.33M	-34.35M	-45.39M	-40.15M	-35.37M	-147.66K	7.08M	-13.00M	-7.72M	-49.73K	-55.78K	-34.37K
Capital Expenditures	-15.29M	-4.81M	-1.46M	-2.50M	-4.04M	-4.66M	-1.35M	-3.14M	-2.36M	-1.37M	-2.30M	-1.41M	-828.51K	-646.54K	-1.46M	-1.16M	-2.37M	-364.80K	-350.89K	-227.95K	-	-	-
Acquisitions	-	-999.12M	404.83M	1.08M	1.51M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of Investments	-292.91M	-255.21M	-652.51M	-226.19M	-389.76M	-311.11M	-398.19M	-155.41M	-71.48M	-88.88M	-48.95M	-	-	-	-	-	-	-	-	-	-	-	-
Sales Maturities Of Investments	211.30M	746.13M	247.68M	305.97M	388.25M	318.27M	235.81M	81.78M	79.73M	57.30M	3.38M	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing Acitivies	-	26.01M	-404.83M	80.86M	-1.51M	7.16M	-162.38M	-73.63M	8.25M	-31.58M	-45.57M	-	-	-	-	-	-	-	-	-	-	-	-
Investing Cash Flow	-96.91M	-487.00M	-406.29M	78.35M	-5.55M	2.49M	-163.73M	-76.77M	5.89M	-32.95M	-47.87M	-1.41M	-828.51K	-646.54K	-1.46M	-1.16M	-2.37M	-364.80K	-350.89K	-227.95K	-	-	-
Debt Repayment	-13.48M	624.55M	415.81M	-19.56M	339.27M	-77.52M	-15.99M	148.76M	-	-	19.99M	29.66M	-	-	-	-	-	-	-	-	-	-	-
Common Stock Repurchased	-402.38M	-200.00M	-350.06M	-150.12M	-200.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Financial Acitivies	7.88M	-62.17M	12.11M	63.39M	13.95M	13.72M	12.78M	1.86M	13.10M	6.79M	25.04B	1.68M	4.75M	1.86M	7.18M	-	-	-	-	7.87M	-	-	-
Financial Cash Flow	-407.99M	362.37M	77.86M	-106.28M	153.22M	-63.80M	131.66M	150.62M	13.10M	114.50M	25.06M	112.82M	4.75M	61.82M	45.36M	2.57M	56.00M	18.34M	16.47M	23.45M	-	126.90K	60.50K
Net Cash Flow	-116.33M	115.48M	-28.98M	27.52M	62.24M	-110.80M	101.98M	23.47M	-18.10M	34.03M	-72.14M	47.08M	-30.43M	15.79M	3.75M	-33.96M	53.49M	25.06M	3.12M	15.50M	-49.73K	71.12K	26.13K
Free Cash Flow	373.28M	235.30M	297.98M	52.95M	-89.46M	-54.16M	132.70M	-53.52M	-39.44M	-48.89M	-51.64M	-65.74M	-35.18M	-46.03M	-41.61M	-36.53M	-2.51M	6.71M	-13.35M	-7.95M	-49.73K	-55.78K	-34.37K